ProMIS Neurosciences
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -9,363 | ||
EBITDA | -8,644 | -10,772 | -11,580 |
EBIT | -21,440 | ||
Net Income | -8,244 | -10,674 | -11,580 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -12,383 | -9,051 | -10,181 |
Cash | 63,814 | 6,116 | 15,399 |
Basic Shares | 6,527 | 1,757 | 1,394 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $8 |
Gross Profit | -33,362 | -10,444 | -15 | |
EBITDA | -39,719 | 2,855 | -17,809 | -17,780,199 |
EBIT | -38,994 | 2,702,098 | -17,837 | -23,890 |
Net Income | -39,719 | 2,778 | -17,506 | -18,062,263 |
Net Change In Cash | 0 | 0 | 0 | 8 |
Free Cash Flow | -28,118 | -27,182 | -10,843 | -22,890 |
Cash | 6,116 | 13,291 | 12,598 | 10,689 |
Basic Shares | 1,756 | 1,058 | 491 | 300 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.28 |
2026-03-31 | -$1.26 |
2025-12-31 | -$30.05 |
2025-09-30 | -$8.40 |